Corteva announces 2019 guidance

On February 21, Corteva Agriscience, DowDuPont’s (DWDP) agriculture division, provided its 2019 guidance in its sell-side analyst meeting. Corteva is scheduled to separate from DowDuPont on June 1. In the meeting, James C. Collins, the CEO-elect, and Greg Friedman, the CFO-elect, addressed and reviewed the strategies and priorities for shareholder value creation.

Corteva Agriscience Provided Its 2019 Guidance

2019 guidance

  • Corteva expects the 2019 sales to remain flat compared to the previous year. The organic growth is expected to be 1%–2%. The company said that there’s currency pressure, especially from the euro and the Brazilian real.
  • The operating EBITDA is expected to be $2.8 billion.
  • The capital expenditure is estimated at $650 million.
  • Corteva expects the operational tax rate to be 19%–21%.

Friedman said, “We continue to drive sales performance by taking full advantage of our robust product pipeline. We are also focused on moving beyond merger-related synergies to delivering productivity, which is a cornerstone of our performance-based culture, and emphasizing continuous improvement across all of our processes.”

DowDuPont’s stock price

DowDuPont’s stock price rose 1.35%% and closed at $54.97 for the week ending February 22. Despite the gain in the stock price, DowDuPont traded 2.14% below the 100-day moving average price of $56.17. DowDuPont’s 100-day moving average has fallen from a high of $67.6 to the current levels in the past six months, which indicates weakness in the stock. However, DowDuPont has risen 3.7% in 2019. DowDuPont’s 14-day relative strength index of 52 indicates that the stock isn’t overbought or oversold.

Investors could hold DowDuPont indirectly by investing in the Materials Select Sector SPDR Fund (XLB). XLB has invested 19.8% of its portfolio in DowDuPont. XLB also provides exposure to Linde (LIN), Air Products and Chemicals (APD), and LyondellBasell (LYB) with weights of 14.7%, 6.2%, and 4.3%, respectively, as of February 22.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.

172.31.59.107